Fytianos, K.; Schliep, R.; Mykoniati, S.; Khan, P.; Hostettler, K.E.; Tamm, M.; Gazdhar, A.; Knudsen, L.; Geiser, T.
Anti-Fibrotic Effect of SDF-1β Overexpression in Bleomycin-Injured Rat Lung. Pharmaceutics 2022, 14, 1803.
https://doi.org/10.3390/pharmaceutics14091803
AMA Style
Fytianos K, Schliep R, Mykoniati S, Khan P, Hostettler KE, Tamm M, Gazdhar A, Knudsen L, Geiser T.
Anti-Fibrotic Effect of SDF-1β Overexpression in Bleomycin-Injured Rat Lung. Pharmaceutics. 2022; 14(9):1803.
https://doi.org/10.3390/pharmaceutics14091803
Chicago/Turabian Style
Fytianos, Kleanthis, Ronja Schliep, Sofia Mykoniati, Petra Khan, Katrin E. Hostettler, Michael Tamm, Amiq Gazdhar, Lars Knudsen, and Thomas Geiser.
2022. "Anti-Fibrotic Effect of SDF-1β Overexpression in Bleomycin-Injured Rat Lung" Pharmaceutics 14, no. 9: 1803.
https://doi.org/10.3390/pharmaceutics14091803
APA Style
Fytianos, K., Schliep, R., Mykoniati, S., Khan, P., Hostettler, K. E., Tamm, M., Gazdhar, A., Knudsen, L., & Geiser, T.
(2022). Anti-Fibrotic Effect of SDF-1β Overexpression in Bleomycin-Injured Rat Lung. Pharmaceutics, 14(9), 1803.
https://doi.org/10.3390/pharmaceutics14091803